協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/07/17 | 3,177 | 3,196 | 3,148 | 3,178 | +78 | +2.5% | 1,078,500 |
2024/07/16 | 3,122 | 3,140 | 3,079 | 3,100 | -7 | -0.2% | 649,400 |
2024/07/12 | 3,100 | 3,128 | 3,043 | 3,107 | +6 | +0.2% | 1,420,700 |
2024/07/11 | 3,110 | 3,129 | 3,089 | 3,101 | -1 | ±0% | 1,113,500 |
2024/07/10 | 3,070 | 3,118 | 3,070 | 3,102 | +18 | +0.6% | 1,250,100 |
2024/07/09 | 2,958.5 | 3,091 | 2,953 | 3,084 | +155.5 | +5.3% | 1,951,500 |
2024/07/08 | 2,904 | 2,933 | 2,896 | 2,928.5 | +18.5 | +0.6% | 817,400 |
2024/07/05 | 2,929.5 | 2,937.5 | 2,889 | 2,910 | -27.5 | -0.9% | 1,103,500 |
2024/07/04 | 2,845 | 2,938.5 | 2,836 | 2,937.5 | +173 | +6.3% | 1,824,700 |
2024/07/03 | 2,775.5 | 2,786.5 | 2,752 | 2,764.5 | -6 | -0.2% | 1,025,100 |
2024/07/02 | 2,755 | 2,773.5 | 2,712.5 | 2,770.5 | -1.5 | -0.1% | 1,241,100 |
2024/07/01 | 2,750.5 | 2,777 | 2,748 | 2,772 | +24.5 | +0.9% | 913,800 |
2024/06/28 | 2,718.5 | 2,749 | 2,718 | 2,747.5 | +22.5 | +0.8% | 819,100 |
2024/06/27 | 2,695.5 | 2,739.5 | 2,681 | 2,725 | -48.5 | -1.7% | 912,400 |
2024/06/26 | 2,748 | 2,780.5 | 2,734.5 | 2,773.5 | +26 | +0.9% | 881,500 |
2024/06/25 | 2,705.5 | 2,750 | 2,705.5 | 2,747.5 | +49 | +1.8% | 708,100 |
2024/06/24 | 2,708 | 2,717 | 2,691.5 | 2,698.5 | +5 | +0.2% | 730,100 |
2024/06/21 | 2,691 | 2,721 | 2,685 | 2,693.5 | +3.5 | +0.1% | 1,153,400 |
2024/06/20 | 2,683 | 2,694.5 | 2,670.5 | 2,690 | +10.5 | +0.4% | 731,100 |
2024/06/19 | 2,650 | 2,679.5 | 2,629.5 | 2,679.5 | +29.5 | +1.1% | 1,431,500 |
2024/06/18 | 2,690.5 | 2,693.5 | 2,644 | 2,650 | -67.5 | -2.5% | 1,424,700 |
2024/06/17 | 2,763.5 | 2,769 | 2,693.5 | 2,717.5 | -30 | -1.1% | 1,072,700 |
2024/06/14 | 2,685 | 2,756.5 | 2,651 | 2,747.5 | +61.5 | +2.3% | 2,426,300 |
2024/06/13 | 2,693 | 2,697.5 | 2,655.5 | 2,686 | -7 | -0.3% | 702,800 |
2024/06/12 | 2,731 | 2,746 | 2,690 | 2,693 | -33.5 | -1.2% | 1,014,200 |
2024/06/11 | 2,727 | 2,737.5 | 2,715 | 2,726.5 | -1 | ±0% | 697,400 |
2024/06/10 | 2,704.5 | 2,743.5 | 2,703 | 2,727.5 | +23 | +0.9% | 817,300 |
2024/06/07 | 2,675 | 2,709 | 2,675 | 2,704.5 | +11.5 | +0.4% | 815,000 |
2024/06/06 | 2,730 | 2,732 | 2,681.5 | 2,693 | -11 | -0.4% | 1,026,300 |
2024/06/05 | 2,722 | 2,731.5 | 2,693 | 2,704 | -4 | -0.1% | 1,013,800 |
2024/06/04 | 2,666 | 2,722.5 | 2,658.5 | 2,708 | +27.5 | +1% | 905,600 |
2024/06/03 | 2,658.5 | 2,711 | 2,654 | 2,680.5 | +25 | +0.9% | 864,800 |
2024/05/31 | 2,600 | 2,655.5 | 2,597.5 | 2,655.5 | +74 | +2.9% | 4,286,700 |
2024/05/30 | 2,559 | 2,590 | 2,536 | 2,581.5 | +22.5 | +0.9% | 866,600 |
2024/05/29 | 2,557.5 | 2,576.5 | 2,550.5 | 2,559 | -16 | -0.6% | 1,053,900 |
2024/05/28 | 2,580 | 2,591.5 | 2,555.5 | 2,575 | -8 | -0.3% | 966,300 |
2024/05/27 | 2,562.5 | 2,586 | 2,540 | 2,583 | +15 | +0.6% | 829,500 |
2024/05/24 | 2,567.5 | 2,575.5 | 2,549.5 | 2,568 | -22 | -0.8% | 844,400 |
2024/05/23 | 2,550 | 2,595.5 | 2,546.5 | 2,590 | +24.5 | +1% | 1,018,900 |
2024/05/22 | 2,586 | 2,592.5 | 2,556 | 2,565.5 | -25.5 | -1% | 856,100 |
2024/05/21 | 2,611 | 2,622.5 | 2,591 | 2,591 | -27.5 | -1.1% | 711,900 |
2024/05/20 | 2,602 | 2,642.5 | 2,602 | 2,618.5 | +6 | +0.2% | 799,100 |
2024/05/17 | 2,621 | 2,641 | 2,593 | 2,612.5 | -41.5 | -1.6% | 987,300 |
2024/05/16 | 2,620 | 2,668.5 | 2,620 | 2,654 | +15 | +0.6% | 972,100 |
2024/05/15 | 2,668.5 | 2,690.5 | 2,627.5 | 2,639 | -55.5 | -2.1% | 1,136,000 |
2024/05/14 | 2,686.5 | 2,716 | 2,675 | 2,694.5 | +23 | +0.9% | 962,400 |
2024/05/13 | 2,653.5 | 2,689.5 | 2,650 | 2,671.5 | +2 | +0.1% | 762,800 |
2024/05/10 | 2,679 | 2,710 | 2,666 | 2,669.5 | +25 | +0.9% | 982,600 |
2024/05/09 | 2,638.5 | 2,698 | 2,634.5 | 2,644.5 | +10 | +0.4% | 1,175,400 |
2024/05/08 | 2,636 | 2,685 | 2,602 | 2,634.5 | -51.5 | -1.9% | 1,917,700 |
101~
150
件表示中 / 3599件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 246,400円 | +11.3% | -5.4% | 2.35% | 18.96倍 | 1.49倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 157,400円 | +12.2% | +180.3% | 4.70% | 56.35倍 | 1.84倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 218,400円 | +5.7% | +3.9% | 2.63% | 10.87倍 | 1.44倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 443,500円 | +1.7% | -2.9% | 3.61% | 29.10倍 | 1.53倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 172,300円 | -3.5% | -50.2% | 4.64% | 13.95倍 | 1.03倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム